India took a much-needed step in the fight against obesity and diabetes with the introduction of Mounjaro (tirzepatide), a ...

Eli Lilly launched its blockbuster diabetes and weight-loss drug Mounjaro in India on Thursday, beating rival Novo Nordisk ...

Eli Lilly launches Mounjaro in India, targeting the $150B weight-loss market. The GLP-1 drug offers diabetes control & major ...

The global weight-loss drug market is expected to reach $150 billion in the next decade. By 2026, semaglutide (the active ...

US -based pharmaceutical giant Eli Lilly recently launched its weight loss drug Mounjaro in India. Tirzepatide is the generic ...

A patient in India may have to spend approximately $200 per month for ... Following marketing authorization from the CDSCO, ...

The new weight loss drug entering the Indian market, Mounjaro, Trinamool Congress' MP Abhishek Banerjee's Diamond Harbour Model and his political ascent in West Bengal and the Waqf Amendment Bill, ...

With the increasing popularity of weight-loss and diabetes medications worldwide, US pharmaceutical giant Eli Lilly has ...

US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...

The drug will be priced at ₹3,500 for a 2.5 mg vial and ₹4,375 for the 5 mg vial. The injectable, to be taken once a week, ...

While many stayed mum about shedding drastic weight, stars like Oprah Winfrey were honest Dubai: With the arrival of Eli Lilly’s weight-loss drug Mounjaro in India today, the conversation around ...